Bio-Rad Laboratories (BIO) vs Circle8 Group (CIRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bio-Rad Laboratories (BIO) has outperformed Circle8 Group (CIRC) over the past year, gaining 24.1% versus a loss of 84.7%. Over five years, BIO leads with a -49.0% price change compared with -99.7% for CIRC. Bio-Rad Laboratories is the larger company by market cap ($9.64 billion vs $51.0 million), about 188.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIO | CIRC |
|---|---|---|
| Share price | $360.40 | $0.446 |
| Market cap | $9.64B | $51.03M |
| 1-day change | -2.04% | -3.04% |
| YTD return | +21.43% | -65.41% |
| 1-year return | +24.08% | -84.67% |
| 5-year return | -49.00% | -99.67% |
| P/E ratio (TTM) | 45.68 | — |
| Forward P/E | 36.34 | — |
| EPS (TTM) | $7.89 | $-2.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.58B | — |
| Revenue growth (YoY) | +0.65% | — |
| Net income (latest FY) | $759.90M | — |
| Gross margin | 51.87% | — |
| Operating margin | 1.83% | — |
| Net margin | 29.42% | — |
| 52-week high | $396.23 | $4.56 |
| 52-week low | $236.73 | $0.313 |
| Distance from 52-week high | -9.04% | -90.22% |
| Analyst consensus | hold | — |
| Avg. price target upside | -8.90% | — |
| Average volume | 278.28K | 1.79M |
| Shares outstanding | 21.68M | 114.41M |
| Employees | 7,450 | 300 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Staffing & Employment Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bio-Rad Laboratories is about 188.9 times larger than Circle8 Group by market value ($9.64B vs $51.03M).
- BIO has outperformed CIRC by 108.7 percentage points over the past year.
About Bio-Rad Laboratories
BIO stock →Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 7,450 employees
About Circle8 Group
CIRC stock →Circle8 Group, Inc. provides talent management services.
Industrials · Staffing & Employment Services · 300 employees
BIO vs CIRC FAQ
Which is bigger, Bio-Rad Laboratories or Circle8 Group?
Bio-Rad Laboratories (BIO) is larger, with a market capitalization of $9.64B compared with $51.03M for Circle8 Group (CIRC).
Which stock has performed better over the past year, BIO or CIRC?
BIO returned +24.08% over the past 12 months, compared with -84.67% for CIRC (price return, excluding dividends). Past performance does not predict future results.
Are Bio-Rad Laboratories and Circle8 Group in the same industry?
Both are in the Industrials sector, but in different industries: Biotechnology: Laboratory Analytical Instruments for Bio-Rad Laboratories and Staffing & Employment Services for Circle8 Group.